Objective: To determine the effect of low and high doses of buspirone on motor activity and striatal monoamine metabolism in rats.
Design: Experimental study.
Place And Duration Of Study: The experiments were performed in the Department of Biochemistry, Karachi University from October to December 2003.
Subjects And Method: Behavioral and neurochemical effects of agents were monitored acutely. Motor activity was scored in open field. Neurochemical estimations in the striatum were carried out by high performance liquid chromatography.
Results: Administration of buspirone at low (1 mg/kg) and high (10 mg/kg) doses increased latency to move in open field and decreased number of squares crossed. The agent injected at a dose of 1 mg/kg decreased dopamine concentration and increased the concentration of homovanillic acid. Increases of homovanillic acid were smaller at a dose of 1 mg/kg than 10 mg/kg. Changes in the levels of dihydroxyphenyl acetic acid were not significant. Administration of buspirone decreased 5-hydroxytryptamine metabolism at a dose of 1 mg/kg but not at a dose of 10 mg/kg.
Conclusion: The present results provide neurochemical evidence that low but not high dose of buspirone preferentially stimulates somatodendritic 5-hydroxytryptamine-1A receptors resulting in a decrease in striatal serotonin metabolism. Low dose of buspirone could release dopaminergic neurons from inhibitory influence of serotonin and may be useful in reducing parkinsonian-like effects of traditional antipsychotics.
Download full-text PDF |
Source |
---|
IBRO Neurosci Rep
December 2024
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Previous investigations have revealed the role of GABAergic and serotonergic systems in the modulation of pain behavior. This research aimed to examine the effects of intracerebroventricular (i.c.
View Article and Find Full Text PDFActa Pharm Sin B
December 2024
State Key Laboratory of Cellular Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Science, Xiamen University, Xiamen 361102, China.
The orphan nuclear receptor Nur77 is emerging as an attractive target for cancer therapy, and activating Nur77's non-genotypic anticancer function has demonstrated strong therapeutic potential. However, few Nur77 site B ligands have been identified as excellent anticancer compounds. There are no co-crystal structures of effective anticancer agents at Nur77 site B, which greatly limits the development of novel Nur77 site B ligands.
View Article and Find Full Text PDFClin Exp Emerg Med
January 2025
Department of Emergency Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: Ketamine is a promising drug for analgesia in emergency medicine, but a high rate of side effects is a barrier to whispered usage. We hypothesized that ketamine bolus followed by ketamine infusion would provide a more even and longer duration of analgesia and lower rates of side effects in comparison to bolus-only administration.
Methods: This was a double-blinded, clinical trial.
Food Funct
January 2025
School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China.
Lactopontin (LPN) is an important milk protein with the potential to improve bone health; however, its specific effects have not been determined. This study aims to investigate the effects of LPN on early bone growth and development. 3 week-old SD rats ( = 32) were assigned to the control group, whey protein concentration (WPC) group, LPN-L (low-dose LPN) group, and LPN-H (high-dose LPN) group, with intragastric administration of deionized water, 65.
View Article and Find Full Text PDFBMC Pharmacol Toxicol
January 2025
Biochemistry Department, Faculty of Science, Ain-Shams University, Cairo, Egypt.
Hepatic encephalopathy (HE) is a syndrome that arises from acute or chronic liver failure. This study was devised to assess the impact of a combination of boswellic acid (BA) and low doses of gamma radiation (LDR) on thioacetamide (TAA)-induced HE in an animal model. The effect of daily BA treatment (175 mg/kg body weight, for four weeks) and/or fractionated low-dose γ-radiation (LDR; 0.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!